Changes in drug use patterns reported on the web after the introduction of ADF OxyContin: findings from the Researched Abuse, Diversion, and Addiction‐Related Surveillance (RADARS) System Web Monitoring Program
- 27 June 2017
- journal article
- research article
- Published by Wiley in Pharmacoepidemiology and Drug Safety
- Vol. 26 (9) , 1044-1052
Abstract
This qualitative study summarizes information that individuals shared online about use of OxyContin following the August 2010 introduction of the abuse deterrent formulation (ADF).Purpose: The primary objective was to study online posts that endorsed continued use of OxyContin or a switch from OxyContin to another formulation of oxycodone or another substance altogether following the introduction of the ADF. A secondary objective was to determine whether posts revealed that the ADF led to cessation of OxyContin use.Methods: Data were collected with the Researched Abuse, Diversion, and Addiction‐Related Surveillance System Web Monitoring Program, an online surveillance system that collects and organizes posts about prescription drugs from social media websites, blogs, and forums from 3Q2009 to 4Q2014 using a commercially available web platform.Results: Posts were categorized by whether they conveyed a switch to drugs other than reformulated OxyContin or a continuation of reformulated OxyContin abuse. “Switch posts” primarily discussed switching to immediate‐release opioids. “Continue abusing” posts identified tampering strategies for alternate routes of administration, oral use, and continued use although post authors were generally unhappy with the experience. No reference to OxyContin cessation as a function of the introduction of the ADF was found; however, discontinued use was discussed.Conclusions: Web Monitoring data are useful for capturing cross sections of Internet conversation reflecting reactions to new drug formulations. These data support the notion that users will gravitate to non‐ADFs generally, and to immediate‐release non‐ADF opioid formulations, specifically, as long as these options remain on the market.Keywords
This publication has 29 references indexed in Scilit:
- An iterative model for in vitro laboratory assessment of tamper deterrent formulationsDrug and Alcohol Dependence, 2013
- Abuse Rates and Routes of Administration of Reformulated Extended-Release Oxycodone: Initial Findings From a Sentinel Surveillance Sample of Individuals Assessed for Substance Abuse TreatmentThe Journal of Pain, 2013
- A comparison among tapentadol tamper‐resistant formulations (TRF) and OxyContin® (non‐TRF) in prescription opioid abusersAddiction, 2013
- Effect of Abuse-Deterrent Formulation of OxyContinNew England Journal of Medicine, 2012
- A History of Being Prescribed Controlled Substances and Risk of Drug Overdose DeathPain Medicine, 2012
- Abuse risks and routes of administration of different prescription opioid compounds and formulationsHarm Reduction Journal, 2011
- Monitoring risk: Post marketing surveillance and signal detectionDrug and Alcohol Dependence, 2009
- Development and validation of the Current Opioid Misuse MeasurePain, 2007
- The Development of a Comprehensive Risk-Management Program for Prescription Opioid Analgesics: Researched Abuse, Diversion and Addiction-Related Surveillance (RADARS®)Pain Medicine, 2007
- Trends in Abuse of OxyContin® and Other Opioid Analgesics in the United States: 2002-2004The Journal of Pain, 2005